Cargando…

Uremic leontiasis ossea due to secondary hyperparathyroidism complicated by vitamin C deficiency in a non-adherent chronic hemodialysis patient: A case report

Non-adherence to medical therapy in patients with end-stage kidney disease (ESKD) can lead to severe metabolic derangements rarely seen in the current medical era. Such complications may take the form of secondary hyperparathyroidism (HPT) leading to rare manifestations of bone mineral disease, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Massicotte-Azarniouch, David, McLean, Laurie, Brown, Pierre Antoine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dustri-Verlag Dr. Karl Feistle 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734544/ https://www.ncbi.nlm.nih.gov/pubmed/31508269 http://dx.doi.org/10.5414/CNCS109788

Ejemplares similares

Uremic Leontiasis Ossea
por: Heard, Bryonna, et al.
Publicado: (2021)

Uremic Leontiasis Ossea in a Pediatric Patient
por: Algossy, Hisham K, et al.
Publicado: (2022)

Uremic leontiasis ossea: distinctive imaging features allow differentiation from other clinical causes of leontiasis ossea
por: Alamer, Ali
Publicado: (2021)

Uremic Leontiasis Ossea in a Patient With End-Stage Renal Disease in Hemodialysis
por: Nasra, Karim, et al.
Publicado: (2020)

Sixty‐Two‐Year‐Old Male Suffering From Uremic Leontiasis Ossea Caused by Severe Secondary Hyperparathyroidism
por: Purrunsing, Yogendranath, et al.
Publicado: (2018)

A Case of Diffuse Leontiasis Ossea
por: Stack, E. H. Edwards
Publicado: (1900)

Three Rare Concurrent Complications of Tertiary Hyperparathyroidism: Maxillary Brown Tumor, Uremic Leontiasis Ossea, and Hungry Bone Syndrome
por: Bransky, Natalie, et al.
Publicado: (2020)

Leontiasis ossea and post traumatic cervical cord contusion in polyostotic fibrous dysplasia
por: Maramattom, Boby Varkey
Publicado: (2006)

Effects of parathyroidectomy on tumoral calcinosis in uremic patients with secondary hyperparathyroidism
por: Wang, Jing, et al.
Publicado: (2019)

MON-368 A Case of Uremic Tumoral Calcinosis with Secondary Hyperparathyroidism
por: Mathew, Justin, et al.
Publicado: (2020)

Hemodialysis patients’ preferences for the management of secondary hyperparathyroidism
por: Hauber, Brett, et al.
Publicado: (2017)

Coagulation and fibrinolysis in hyperparathyroidism secondary to vitamin D deficiency
por: Elbers, Laura P B, et al.
Publicado: (2018)

Pharmacodynamics of evocalcet for secondary hyperparathyroidism in Japanese hemodialysis patients
por: Shigematsu, Takashi, et al.
Publicado: (2018)

Maxillary and Frontal Bone Simultaneously Involved in Brown Tumor due to Secondary Hyperparathyroidism in a Hemodialysis Patient
por: Artul, Suheil, et al.
Publicado: (2013)

Parathyroidectomy Is Associated with Reduced Mortality in Hemodialysis Patients with Secondary Hyperparathyroidism
por: Ma, Tsung-Liang, et al.
Publicado: (2015)

PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism
por: Akizawa, Tadao, et al.
Publicado: (2016)

Parathyroidectomy Versus Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
por: Alvarado, Luis, et al.
Publicado: (2022)

Paricalcitol in hemodialysis patients with secondary hyperparathyroidism and its potential benefits
por: Chen, Xiu, et al.
Publicado: (2021)

215 A Case of Calcific Uremic Arteriolopathy With Severe Secondary Hyperparathyroidism, How High Is High?
Publicado: (2022)

Maxillary brown tumor due to secondary hyperparathyroidism in a Hemodialysis patient: A case report and literature review
por: Aravindhan, R, et al.
Publicado: (2021)

The Effect of Vitamin C on Parathyroid Hormone in Patients on Hemodialysis With Secondary Hyperparathyroidism: A Double Blind, Placebo-Controlled Study
por: Biniaz, Vajihe, et al.
Publicado: (2013)

Efficacy of microwave ablation for severe secondary hyperparathyroidism in subjects undergoing hemodialysis
por: Diao, Zongli, et al.
Publicado: (2016)

Etelcalcetide Is Effective at All Levels of Severity of Secondary Hyperparathyroidism in Hemodialysis Patients
por: Cunningham, John, et al.
Publicado: (2019)

Fibrous dysplasia in maxilla in a patient on hemodialysis with severe secondary hyperparathyroidism
por: Yang, Hui-Hsin, et al.
Publicado: (2022)

Diabetes due to recurrent pancreatitis secondary to hypercalcemia due to primary hyperparathyroidism
por: Chakrabarti, Sumit Kumar, et al.
Publicado: (2013)

SAT214 A Rare Case Of Biopsy-proven Non-uremic Calciphylaxis In A Patient With Secondary Hyperparathyroidism
por: Annabel Ogar, Ufeh, et al.
Publicado: (2023)

Treatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism
por: Kuczera, Piotr, et al.
Publicado: (2016)

An integrated analysis of safety and tolerability of etelcalcetide in patients receiving hemodialysis with secondary hyperparathyroidism
por: Block, Geoffrey A., et al.
Publicado: (2019)

Etelcalcetide in Patients on Hemodialysis with Severe Secondary Hyperparathyroidism. Multicenter Study in “Real Life”
por: Russo, Domenico, et al.
Publicado: (2019)

One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism
por: Bushinsky, David A, et al.
Publicado: (2019)

One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism
por: Bushinsky, David A, et al.
Publicado: (2019)

Predictive factors requiring high-dose evocalcet in hemodialysis patients with secondary hyperparathyroidism
por: Tokumoto, Masanori, et al.
Publicado: (2022)

Observation of the efficacy of parathyroidectomy for secondary hyperparathyroidism in hemodialysis patients: a retrospective study
por: Qiu, Wenqiang, et al.
Publicado: (2023)

Exacerbation of Hyperparathyroidism, Secondary to a Reduction in Kidney Function, in Individuals With Vitamin D Deficiency
por: Daimon, Makoto, et al.
Publicado: (2020)

Vitamin D deficiency, secondary hyperparathyroidism and respiratory insufficiency in hospitalized patients with COVID-19
por: Mazziotti, G., et al.
Publicado: (2021)

The Emerging Role of Nutritional Vitamin D in Secondary Hyperparathyroidism in CKD
por: Lu, Chien-Lin, et al.
Publicado: (2018)

Evocalcet with vitamin D receptor activator treatment for secondary hyperparathyroidism
por: Shigematsu, Takashi, et al.
Publicado: (2022)

Effect of hemodialysis fluid cooling uremic pruritus in hemodialysis patients
por: Tamadon, Mohammad-Reza
Publicado: (2012)

Cholecalciferol Additively Reduces Serum Parathyroid Hormone and Increases Vitamin D and Cathelicidin Levels in Paricalcitol-Treated Secondary Hyperparathyroid Hemodialysis Patients
por: Zheng, Jing-Quan, et al.
Publicado: (2016)

Redox State of Human Serum Albumin and Inflammatory Biomarkers in Hemodialysis Patients with Secondary Hyperparathyroidism During Oral Calcitriol Supplementation for Vitamin D
por: Nasif, Wesam A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sbds7fkd6jrig7g9jf4bgqkvdf